Stockscreener 앱 받기
1.835
5.64%
-0.115
전일 마감가:
$1.95
열려 있는:
$1.88
하루 거래량:
14.41M
Relative Volume:
1.13
시가총액:
$664.00M
수익:
$241.53M
순이익/손실:
$-389.92M
주가수익비율:
-1.4919
EPS:
-1.23
순현금흐름:
$-323.54M
1주 성능:
-15.98%
1개월 성능:
-21.37%
6개월 성능:
-47.43%
1년 성능:
-83.92%
1일 변동 폭
$1.805
$1.93
1주일 범위
$1.805
$2.20
52주 변동 폭
$1.6385
$12.51
Iovance Biotherapeutics Inc Stock (IOVA) Company Profile
명칭
Iovance Biotherapeutics Inc
전화
(650) 260-7120
주소
825 INDUSTRIAL ROAD, SAN CARLOS
IOVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IOVA
Iovance Biotherapeutics Inc
|
1.835 | 705.62M | 241.53M | -389.92M | -323.54M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.69 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.03 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.96 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.90 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.67 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-05-12 | 다운그레이드 | Truist | Buy → Hold |
| 2025-05-09 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-07-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-11-20 | 개시 | Goldman | Buy |
| 2023-09-18 | 재확인 | Barclays | Overweight |
| 2023-05-30 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-03-27 | 재개 | Wells Fargo | Equal Weight |
| 2023-01-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-12-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-10-31 | 개시 | Guggenheim | Neutral |
| 2022-08-18 | 재개 | Wells Fargo | Equal Weight |
| 2022-01-28 | 업그레이드 | Stifel | Hold → Buy |
| 2021-12-07 | 재개 | Cowen | Outperform |
| 2021-06-10 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2021-05-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-05-19 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-05-19 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-05-03 | 개시 | Truist | Buy |
| 2021-04-16 | 개시 | Goldman | Buy |
| 2021-03-08 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-12-15 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-10-06 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-04-22 | 개시 | Mizuho | Buy |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2020-02-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-02-26 | 재확인 | Oppenheimer | Outperform |
| 2019-12-18 | 개시 | JMP Securities | Mkt Outperform |
| 2019-10-01 | 개시 | Stifel | Buy |
| 2019-04-29 | 개시 | Piper Jaffray | Overweight |
| 2019-02-28 | 재확인 | Chardan Capital Markets | Buy |
| 2019-02-07 | 개시 | Robert W. Baird | Outperform |
| 2018-12-31 | 재개 | B. Riley FBR | Buy |
| 2018-07-06 | 재확인 | Chardan Capital Markets | Buy |
| 2018-04-10 | 업그레이드 | B. Riley FBR, Inc. | Neutral → Buy |
| 2018-03-13 | 재확인 | B. Riley FBR, Inc. | Neutral |
| 2018-02-23 | 다운그레이드 | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-01-25 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-01 | 재확인 | B. Riley FBR, Inc. | Buy |
모두보기
Iovance Biotherapeutics Inc 주식(IOVA)의 최신 뉴스
Iovance Biotherapeutics (NASDAQ:IOVA) Shares Gap UpHere's What Happened - MarketBeat
What Wall Street predicts for Iovance Biotherapeutics Inc. stock priceFed Meeting & Risk Controlled Stock Pick Alerts - newser.com
Strategies to average down on Iovance Biotherapeutics Inc.July 2025 Recap & AI Enhanced Trading Alerts - newser.com
Quantitative breakdown of Iovance Biotherapeutics Inc. recent moveWeekly Stock Recap & Weekly High Return Forecasts - newser.com
Published on: 2025-11-04 02:35:47 - newser.com
Can Iovance Biotherapeutics Inc. stock deliver strong Q4 earningsQuarterly Growth Report & Technical Buy Zone Confirmations - newser.com
Iovance Stock Faces Tough Times - timothysykes.com
Iovance Shares Surge on Groundbreaking Lung Cancer Trial Results - AD HOC NEWS
Why Iovance Biotherapeutics Inc. stock is favored by top institutions - newser.com
Iovance Biotherapeutics Stock Rises Premarket on Positive Trial Data for Cancer Drug - MarketScreener
Why Iovance Biotherapeutics Inc. stock appeals to analystsQuarterly Market Summary & Daily Stock Trend Watchlist - newser.com
Why Iovance Biotherapeutics Inc. stock attracts global investors2025 Market Sentiment & Community Driven Trade Alerts - newser.com
Iovance (IOVA) Reports Promising Interim Results from Phase 2 Tr - GuruFocus
Does Iovance Biotherapeutics Inc. stock trade at a discount to peersOptions Play & Free Expert Verified Stock Movement Alerts - newser.com
What insider trading reveals about Iovance Biotherapeutics Inc. stockJobs Report & Free Technical Pattern Based Buy Signals - newser.com
What MACD trends signal for Iovance Biotherapeutics Inc. (2LB) stockJuly 2025 Sector Moves & Safe Swing Trade Setups - newser.com
Automated trading signals detected on Iovance Biotherapeutics Inc.Weekly Trading Summary & Fast Gaining Stock Reports - newser.com
Iovance (NASDAQ: IOVA) lifileucel posts 26% ORR in NSCLC; mDOR not reached at 25.4 months - Stock Titan
How big funds are accumulating Iovance Biotherapeutics Inc. (2LB) stockOil Prices & Fast Entry and Exit Trade Plans - newser.com
Is Iovance Biotherapeutics Inc. stock a good choice for value investorsJuly 2025 Summary & Risk Managed Investment Signals - newser.com
Published on: 2025-11-03 05:20:39 - newser.com
What earnings margins imply for Iovance Biotherapeutics Inc. (2LB) stockWeekly Gains Report & Consistent Profit Alerts - newser.com
Published on: 2025-11-03 03:17:06 - newser.com
Is it time to cut losses on Iovance Biotherapeutics Inc.2025 Breakouts & Breakdowns & Low Risk High Win Rate Picks - newser.com
Using portfolio simulators with Iovance Biotherapeutics Inc. includedMarket Growth Review & Weekly Watchlist for Hot Stocks - newser.com
Will Iovance Biotherapeutics Inc. stock gain from lower inflationWeekly Trend Recap & Step-by-Step Swing Trade Plans - newser.com
Can trapped investors hope for a rebound in Iovance Biotherapeutics Inc.July 2025 Sentiment & Stepwise Trade Execution Plans - newser.com
Iovance Biotherapeutics reports positive interim data for NSCLC therapy - Traders Union
Will Iovance Biotherapeutics Inc. stock beat EPS estimatesMarket Activity Summary & Free Daily Entry Point Trade Alerts - newser.com
Published on: 2025-11-02 22:26:15 - newser.com
Iovance Biotherapeutics Stock Hits Day Low of $2 Amid Price Pressure - Markets Mojo
Is Iovance Biotherapeutics Inc. stock poised for growthWeekly Risk Report & Trade Opportunity Analysis Reports - newser.com
Will Iovance Biotherapeutics Inc. stock see PE expansion2025 Price Action Summary & High Conviction Investment Ideas - newser.com
How Iovance Biotherapeutics Inc. stock trades during market volatilityJuly 2025 Highlights & Reliable Entry Point Trade Alerts - newser.com
How supply shortages influence Iovance Biotherapeutics Inc. (2LB) stockNew Guidance & Free Expert Approved Momentum Trade Ideas - newser.com
Iovance Biotherapeutics, Inc. (IOVA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
HC Wainwright Issues Negative Forecast for IOVA Earnings - MarketBeat
Published on: 2025-11-01 04:05:22 - newser.com
Iovance Biotherapeutics Inc (IOVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):